Latest filing published 11 Dec 2025 for LifeMD, Inc., €47k. Read the official filing
Jessica Friedeman discloses dealings in LifeMD, Inc. to SEC (Form 4). We count 5 filings; the first trade dates from 3 January 2023 and the latest from 9 December 2025.
The open-market record consists of 2 sales worth €203k, with no purchase. Outside the open market, there are 3 share grants. 2025 to date brings no purchases and 2 sales.
On 11 December 2025 came the latest disclosure, an open-market sale for €47k in LifeMD, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations